| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.4 |